Overview

  • Product nameSP600125
  • Description
    JNK inhibitor
  • Biological descriptionPotent and selective JNK1, -2, and -3 inhibitor (IC50 = 0.11 μM). SP600125 is a reversible ATP-competitive inhibitor with >20-fold selectivity over a range of kinases. It dose-dependently inhibits the phosphorylation of c-Jun and the expression of inflammatory genes COX-2, IL-2, IFNγ and TNFα. Neuroprotective in vivo.
  • Purity> 98%

Properties

    Associated products

    References for SP600125 (ab120065)

    This product has been referenced in:
    • Guan QH  et al. Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Brain Res 1092:36-46 (2006). Read more (PubMed: 16674927) »
    • Heo YS  et al. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J 23:2185-95 (2004). Read more (PubMed: 15141161) »
    • Bennett BL  et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98:13681-6 (2001). Read more (PubMed: 11717429) »

    See all 6 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120065.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"